U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07237178) titled 'PROMBot-HSM-FA: Protocol for a Feasibility Study of a WhatsApp-based Chatbot to Collect Patient-reported Outcomes After AF Ablation' on Nov. 14.
Brief Summary: The goal of this clinical trial is to learn if using a WhatsApp-based chatbot called PROMBot-FA can help people recover after atrial fibrillation ablation. The main questions it aims to answer are:
* Is the chatbot easy and practical for people to use after their procedure?
* Do people find the chatbot helpful for sharing their symptoms and health updates?
Researchers will compare follow-up care supported by the chatbot to standard hospital follow-up visits. Participants w...